Get started with Expert Institute

I need help with...*
Case Theory

The link between GLP-1 agonists and gastroparesis

Ozempic pen

Semaglutide, sold under the brand names Ozempic® and Wegovy®, is a GLP-1 receptor agonist used for diabetes management and weight loss. Recent findings suggest a potential link between this drug and gastroparesis, which affects stomach emptying. The Obesity Medicine Association has highlighted the possible effects of GLP-1RA medications on gastric motility.



Despite this, these drugs have been extensively marketed to the public, and the medical community as a safe, and effective treatment option. This raises an important issue: were the potential risks of gastroparesis sufficiently communicated to the countless individuals who placed their trust in its benefits?

Solutions for every stage of your case.

Optimize firm performance throughout the entire case lifecycle.

Close Icon

Research Guides

Dive into litigation research that bolsters your legal theory and highlights prevailing counterarguments, ensuring you're primed to address the most pivotal questions, whether at deposition or trial.

Close Icon

Medical Chronologies

Enhance your understanding of a client's medical history with smart, digitized, hyperlinked, and searchable medical chronologies.

Close Icon

Medical Record Reviews

Our physicians can review medical records to determine whether your client's gastrointestinal issues are due to their reliance on Ozempic® or similar drugs.

Close Icon

Expert Search

We’ll help you retain an industry-leading expert specializing in Endocrinology, Gastroenterology, FDA Regulations and more.

Close Icon

Expert Radar

Know everything about defense experts, and your own experts, including all of their litigation history, Daubert challenges, deposition / trial transcripts, malpractice claims, board sanctions, and more.

Close Icon

Mass Tort Accelerator

Access a suite of case evaluation tools designed to refine your mass tort intake strategy and equip you to handle complex litigation effectively.

Contact us today to build a stronger case.